Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1991
06/21/1991WO1991009132A1 Cloning vector for use in lactic acid bacteria and a method for constructing the same
06/21/1991WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)
06/21/1991WO1991009073A1 Uncharged morpholino-based polymers having achiral intersubunit linkages
06/21/1991CA2018377A1 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
06/20/1991WO1991009126A1 Production of human basic fgf mutein
06/20/1991CA2070989A1 Production of human basic fgf mutein
06/20/1991CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/19/1991WO1991008752A1 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
06/19/1991EP0433225A1 Process for the production of biologically active protein (e.g. TGF)
06/19/1991EP0433113A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof
06/19/1991EP0433088A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/19/1991EP0433074A1 Method for treating cardiac malfunction
06/19/1991EP0432965A1 Malaria vaccine
06/19/1991EP0432691A1 An assay for direct binding of peptides that are T-cell epitopes to MHC gene products on intact antigen-presenting cells and the use thereof for screening susceptibility to autoimmune diseases
06/19/1991EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells
06/19/1991EP0432490A2 Immunostimulant agent
06/19/1991EP0432419A1 Method for solubilization and naturation of somatotropins utilizing low urea concentration
06/19/1991EP0432400A2 Pharmacologically active substance BPC, the process for its preparation and its use in the therapy
06/19/1991EP0432218A1 Method for detecting cellular pathology.
06/19/1991EP0432216A1 Recombinant retroviruses with amphotropic and ecotropic host ranges
06/19/1991EP0432203A1 Legionellosis vaccines and methods for their production
06/19/1991EP0432196A1 Vaccine
06/19/1991EP0309559A4 Transgenic animals
06/19/1991EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use
06/19/1991EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications
06/19/1991CN1052332A Process for producing des(64,65)-proinsulin
06/19/1991CN1052331A Novel antigens and methods therefor
06/19/1991CN1052310A Hiv related peptides
06/19/1991CA2032405A1 Organic compounds
06/18/1991US5024947 Containing a basal medium, a lipid, a peptone and a protective agent
06/18/1991US5024944 Tissue culturing with 1-naphthaleneacetic acid as auxin
06/18/1991US5024940 Nucleic acids encoding the delta chain of the T cell antigen receptor
06/18/1991US5024939 Transient expression system for producing recombinant protein
06/18/1991US5024938 Culturing
06/18/1991US5024837 Bacillus thuringiensis with acquired toxin-encoding plasmid; genetic engineering
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/18/1991US5024828 Iodine-labeled isomers and racemic mixtures for radioimmuno-assays of physiological fluids
06/18/1991CA1285099C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
06/18/1991CA1284931C Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
06/16/1991CA2032430A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
06/16/1991CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/16/1991CA2031831A1 Production method for foreign protein
06/15/1991WO1991008755A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity
06/15/1991CA2071512A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity
06/15/1991CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/15/1991CA2017389A1 Alteration of ability of soluble cd4 protein to bind class ii mhc antigens
06/14/1991CA2071858A1 Hiv-1 env fragment fusion protein
06/14/1991CA2032079A1 Method for treating cardiac malfunction
06/13/1991WO1991008488A1 Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma
06/13/1991WO1991008483A1 Endothelial-derived il-8
06/13/1991WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
06/13/1991WO1991008310A1 Detection of human adenovirus
06/13/1991WO1991008306A1 Polymorphism of human platelet membrane glycoprotein iib and diagnostic and therapeutic applications thereof
06/13/1991WO1991008305A1 Dna fragments and dna probes and primers based thereon
06/13/1991WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
06/13/1991WO1991008297A1 Methods and materials for expression of human plasminogen variant
06/13/1991WO1991008296A1 Cdna of orsv gene
06/13/1991WO1991008293A1 DNA PROBES SPECIFIC FOR $i(PLASMODIUM VIVAX)
06/13/1991WO1991008291A2 Latency associated peptide and uses therefor
06/13/1991WO1991008290A1 RECOMBINANT GENE ENCODING HUMAN MACROPHAGE CARBOHYDRATE AND IgE-BINDING PROTEIN
06/13/1991WO1991008289A1 Sperm specific nuclear autoantigenic protein
06/13/1991WO1991008232A1 Cloning and expression of the blood-brain-barrier-specific protein ht7
06/13/1991WO1991008231A1 [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
06/13/1991WO1991008230A1 Versican core protein
06/13/1991WO1991008229A1 Hirudine polyalkylene glycol conjugates
06/13/1991WO1991008228A1 Leucocyte elastasis and cathepsin g-blocking peptide
06/13/1991WO1991008227A1 NEW HIV-1 p17 PEPTIDES, DIAGNOSTIC ANTIGENS AND IMMUNOASSAY METHOD
06/13/1991WO1991008226A1 Sperm antigen corresponding to a sperm autoantigenic epitope and methods of using the same
06/13/1991WO1991008225A1 Hexapeptides with sulphate ester groups
06/13/1991WO1991008224A1 Im peptides
06/13/1991WO1991008223A1 Novel peptides derived from neuropeptide y
06/13/1991WO1991008217A1 Human intestinal mucins
06/13/1991WO1991008216A1 Production of recombinant polypeptides by bovine species and transgenic methods
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/13/1991WO1991007982A1 Treatment of hsv
06/13/1991WO1991002062A3 C-erbb-2 external domain: gp75
06/13/1991DE3940527A1 Prodn. of HIV-1 regulatory protein NEF
06/13/1991CA2351200A1 Production of recombinant polypeptides by bovine species and transgenic methods
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0431950A1 Assaying interferons
06/12/1991EP0431926A1 Process for producing des(64,65)-proinsulin
06/12/1991EP0431882A2 Pre-activated proteins for labelling oligonucleotide probes
06/12/1991EP0431880A1 Mutant fungal strain detection
06/12/1991EP0431829A1 Insecticidal toxins in plants
06/12/1991EP0431784A2 Methods for treating retroviral infection
06/12/1991EP0431679A1 Method of stabilizing recombinant hepatitis B virus surface proteins from yeast
06/12/1991EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
06/12/1991EP0431541A2 Toxoplasma gondii antigen, its production and use
06/12/1991EP0431400A1 Twodimensional crystallised macromolecular layers
06/12/1991EP0431350A1 New polypeptide compound and a process for preparation thereof
06/12/1991EP0431327A1 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
06/12/1991EP0431323A1 Antitumor antibiotic BU-3983T
06/12/1991EP0431156A1 Vaccine against bovine leukemia virus
06/12/1991EP0431128A1 Self-assembled, defective, non-self-propagating viral particles
06/12/1991EP0431113A1 Atrial peptide derivatives
06/12/1991EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
06/12/1991EP0431065A1 A FULL LENGTH cDNA ENCODING A HUMAN LAMININ BINDING PROTEIN
06/12/1991EP0431064A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus
06/12/1991EP0431045A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids
06/12/1991EP0431042A1 A method of preparing an active human neutrophil chemotactic factor polypeptide.
1 ... 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 ... 2916